DESTIN STONE: Open Payments
NPI 1134779440 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 16 payments from 10 companies in 2025. Trend: 2023 $366 · 2024 $66 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Tris Pharma Inc | 2 | $48 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: REXULTI, FANAPT, UZEDY, Dyanavel XR, ABILIFY ASIMTUFII, INGREZZA, TRINTELLIX, LYBALVI.
Industry payments across TX — which companies pay providers there.
